Kanise, H.; van Oosterhout, J.J.; Bisani, P.; Songo, J.; Matola, B.W.; Chipungu, C.; Simon, K.; Cox, C.; Hosseinipour, M.C.; Sagno, J.-B.;
et al. Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program. Viruses 2024, 16, 29.
https://doi.org/10.3390/v16010029
AMA Style
Kanise H, van Oosterhout JJ, Bisani P, Songo J, Matola BW, Chipungu C, Simon K, Cox C, Hosseinipour MC, Sagno J-B,
et al. Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program. Viruses. 2024; 16(1):29.
https://doi.org/10.3390/v16010029
Chicago/Turabian Style
Kanise, Hope, Joep J. van Oosterhout, Pachawo Bisani, John Songo, Bilaal W. Matola, Chifundo Chipungu, Katherine Simon, Carrie Cox, Mina C. Hosseinipour, Jean-Batiste Sagno,
and et al. 2024. "Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program" Viruses 16, no. 1: 29.
https://doi.org/10.3390/v16010029
APA Style
Kanise, H., van Oosterhout, J. J., Bisani, P., Songo, J., Matola, B. W., Chipungu, C., Simon, K., Cox, C., Hosseinipour, M. C., Sagno, J.-B., Hoffman, R. M., Wallrauch, C., Phiri, S., Steegen, K., Jahn, A., Nyirenda, R., & Heller, T.
(2024). Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program. Viruses, 16(1), 29.
https://doi.org/10.3390/v16010029
